Researchers at the Paul Scherrer Institute (PSI) in canton Aargau have developed a method for treating a particularly malignant form of thyroid cancer. A first study of the treatment’s effectiveness will be conducted on patients at the University Hospital of Basel.
This content was published on
2 minutes
swissinfo.ch and agencies, swissinfo.ch and agencies
The new method is aimed at medullary thyroid carcinoma, which is currently untreatable with available therapies.
The investigators used a protein similar to gastrin, which is a hormone produced by the body, and marked it with a radioactive substance. The substance can attach itself to the surface of tumour cells and then destroy them in a targeted manner with its radioactivity, without harming surrounding tissue.
In one in four cases medullary thyroid carcinoma is transmitted genetically, meaning it can affect children and young adults. PSI chemist Martin Béhé said in a statement on Wednesday that if caught early, the cancer can be cured by surgically removing the thyroid, a large ductless gland in the neck, and administering chemotherapy.
“Once the tumour has metastasised, however, it is virtually incurable,” Béhé said.
The research, which involved testing 12 different radioactively marked proteins until the right one was identified, was conducted by Béhé as well as several other European scientists under the European Cooperation in Science and TechnologyExternal link (COST) project.
Once the treatment is approved for clinical trials, it will be tested on patients by doctors at the University of Basel. The study has already received ethics committee approval and is supported by the Swiss League against CancerExternal link.
You can find an overview of ongoing debates with our journalists here. Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Banana skins can help identify stages of melanoma
This content was published on
When bananas age they become covered in black spots caused by the enzyme tyrosinase. It is a natural browning process common among certain organisms, including food. This same enzyme also plays a role in the type of skin cancer known as melanoma. This cancer’s tell-tale spots are the result of a malfunction in the regulation…
This content was published on
Switzerland has joined an unprecedented scientific collaboration to accelerate nanomedicine testing in a bid to conquer a common enemy: cancer.
This content was published on
A study by a team of scientists in Italy and the United States says babies born to mothers living in the contaminated area of Seveso are still over six times more likely to have altered thyroid function than those born in a non-contaminated area. The findings are based on medical checks between 1994 and 2005…
This content was published on
Game-changing new technologies and treatments are transforming the practice of medicine, dramatically altering the patient experience, and creating conditions for even more breakthroughs. The proof is in the data. Last year, a record 61 drugs were introduced worldwide, compared with an annual average of 34 in the previous decade. More than 40% of these treatments…
You can find an overview of ongoing debates with our journalists here. Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.